Latest Emergency contraception Stories
MORRISTOWN, N.J., Dec. 1, 2010 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI), announced today that ellaÂ® (ulipristal acetate) 30 mg, a novel oral emergency contraceptive, is now available for patients by prescription in the U.S. ellaÂ® was approved by the U.S.
CHAPEL HILL, N.C., Nov.
The Obama administration's health care reform legislation includes a guarantee of access to free preventative medicine for women, but that promise has sparked a debate as to whether or not birth control should be provided at no cost under the new law.
CHAPEL HILL, N.C., Oct.
Global Contraceptives Market is Projected to Reach US$17.2 Billion by 2015, According to New Report by Global Industry Analysts, Inc. GIA announces the release of a comprehensive global report on Contraceptives market.
WASHINGTON, Oct. 1 /PRNewswire-USNewswire/ -- U.S. Centers for Disease Control and Prevention officials have disclosed that two mifepristone (RU-486)-induced deaths occurred in the past two years, bringing the total number of reported death related to RU-486 to 12.
PARIS and MORRISTOWN, N.J., Sept. 17 /PRNewswire-FirstCall/ -- HRA Pharma, a privately-held, European pharmaceutical company that develops healthcare solutions in reproductive health and endocrinology and makes them available worldwide, and Watson Pharmaceuticals, Inc.
The US Food and Drug Administration approved a new, longer-lasting contraceptive pill on Friday that promises to prevent pregnancy up to five days after unprotected sex.
- To give a box on the ear to.